Endovia Health Sciences, Inc. (SBEV)
NYSE
0.1460
-0.01 (-6.41%)
Closed
Oct 12, 2026
Day's Range
0.14000.1512
52 wk Range
0.140013.40
Financial Statements - SBEV - Endovia Health Sciences, Inc.
Revenue
73.06K▼ 98.2%
Net Income
-25.23M▼ 6.2%Net Margin -34537.0%
EBITDA
-13.94M▲ 10.1%
Free Cash Flow
-4.78M▲ 40.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 73.06K | 4.15M | 18.85M | 18.08M | 11.31M | 2.30M |
| Cost of Goods | 56.16K | 3.79M | 13.28M | 12.16M | 7.39M | 1.93M |
| Gross Profit | 16.89K | 355.45K | 5.56M | 5.91M | 3.91M | 363.59K |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -14.18M | -16.04M | -15.28M | -21.39M | -29.08M | -17.66M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -5.79M | -332.55K | -30.32K | - | 179.71K | 54.39K |
| Pre Tax Income | -24.34M | -23.75M | -21M | -21.64M | -29.34M | -19.58M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -25.23M | -23.75M | -21M | -21.69M | -29.05M | -28.67M |
| EPS Basic | -47.88 | -17.68 | -0.49 | -0.58 | -1 | -1.55 |
| EPS Diluted | -47.88 | -17.68 | -0.49 | -0.58 | -1 | -1.55 |
| Basic Shares Outstanding | 544.59K | 1.33M | 42.44M | 37.38M | 28.90M | 37.07M |
| Diluted Shares Outstanding | 544.59K | 1.33M | 42.44M | 37.38M | 28.90M | 37.07M |
| Ebit | -19.98M | -16.37M | -15.31M | -21.38M | -28.90M | -17.60M |
| Ebitda | -13.94M | -15.50M | -14.76M | -20.45M | -28.96M | -17.53M |
| Net Income Continuous Operations | -24.34M | -23.75M | -21M | -21.69M | -29.05M | -28.67M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
